Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases.
about
Reducing tumor growth and angiogenesis using a triple therapy measured with Contrast-enhanced ultrasound (CEUS)Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesisInhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice.A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data.Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells.A deficiency of uPAR alters endothelial angiogenic function and cell morphology.Cathepsin B as a cancer targetRadiation-inducible silencing of uPA and uPAR in vitro and in vivo in meningioma.Association between the polymorphisms of urokinase plasminogen activation system and cancer risk: a meta-analysis.
P2860
Q30411344-7A30E994-9BE6-4D87-B99A-79E306771A80Q33539986-C2FEC4A9-9835-4FB5-B190-E36726583E9BQ33559683-84EDD3E5-612F-4087-A837-53EBCB171B7AQ33640030-B1CFFEF1-295A-4BB2-8CBB-DFD5DE23D38DQ33787296-66974374-68AE-44F9-80E0-8224055B7994Q34621046-FA7F41C1-0365-4263-9C9A-6346706AF12CQ35019176-639D6912-10BF-45EB-9126-668088D7B791Q38072054-B2850835-4AAD-41DC-9280-AA1D183F808BQ39589853-89261BAF-95C4-4500-8232-4EA5F0320D72Q40988377-AB66FA21-D2F1-41DD-B2EA-56607A841A11
P2860
Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator, its receptor, and matrix metalloproteinases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic potential of siRNA ...... and matrix metalloproteinases.
@en
Therapeutic potential of siRNA ...... and matrix metalloproteinases.
@nl
type
label
Therapeutic potential of siRNA ...... and matrix metalloproteinases.
@en
Therapeutic potential of siRNA ...... and matrix metalloproteinases.
@nl
prefLabel
Therapeutic potential of siRNA ...... and matrix metalloproteinases.
@en
Therapeutic potential of siRNA ...... and matrix metalloproteinases.
@nl
P2860
P1476
Therapeutic potential of siRNA ...... and matrix metalloproteinases.
@en
P2093
Jasti S Rao
P2860
P304
P356
10.1007/978-1-60327-547-7_13
P407
P577
2009-01-01T00:00:00Z